<?xml version='1.0' encoding='utf-8'?>
<document id="9506012"><sentence text="Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics."><entity charOffset="34-47" id="DDI-PubMed.9506012.s1.e0" text="valproic acid" /></sentence><sentence text="Nonlinear mixed effects modeling (NONMEM) was used to estimate the effects of drug-drug interaction on valproic acid relative clearance values using 792 serum levels gathered from 400 pediatric and adult patients with epilepsy (age range, 0"><entity charOffset="103-116" id="DDI-PubMed.9506012.s2.e0" text="valproic acid" /></sentence><sentence text="3-54" /><sentence text="8 years) during their clinical routine care" /><sentence text=" Patients received valproic acid as monopharmacy or in combination with either the antiepileptic drugs, phenobarbital, or carbamazepine"><entity charOffset="19-32" id="DDI-PubMed.9506012.s5.e0" text="valproic acid" /><entity charOffset="104-117" id="DDI-PubMed.9506012.s5.e1" text="phenobarbital" /><entity charOffset="122-135" id="DDI-PubMed.9506012.s5.e2" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.9506012.s5.e0" e2="DDI-PubMed.9506012.s5.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s5.e0" e2="DDI-PubMed.9506012.s5.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s5.e0" e2="DDI-PubMed.9506012.s5.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s5.e1" e2="DDI-PubMed.9506012.s5.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s5.e1" e2="DDI-PubMed.9506012.s5.e2" /></sentence><sentence text=" The final model describing valproic acid relative clearance was CL (mL/hr/kg) = 15"><entity charOffset="28-41" id="DDI-PubMed.9506012.s6.e0" text="valproic acid" /></sentence><sentence text="6" /><sentence text="TBW (kg)-0" /><sentence text="252" /><sentence text="DOSE (mg/kg/day)0" /><sentence text="183" /><sentence text="0" /><sentence text="898GEN" /><sentence text="COPB" /><sentence text="COCBZ, where COPB equals 1"><entity charOffset="0-5" id="DDI-PubMed.9506012.s15.e0" text="COCBZ" /></sentence><sentence text="10 if the patient is treated with phenobarbital, a value of unity otherwise, and COCBZ equals 0"><entity charOffset="34-47" id="DDI-PubMed.9506012.s16.e0" text="phenobarbital" /><entity charOffset="81-93" id="DDI-PubMed.9506012.s16.e1" text="COCBZ" /><pair ddi="false" e1="DDI-PubMed.9506012.s16.e0" e2="DDI-PubMed.9506012.s16.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s16.e0" e2="DDI-PubMed.9506012.s16.e1" /></sentence><sentence text="769" /><sentence text="DOSE (mg/kg/day)0" /><sentence text="179 if the patient is treated with carbamazepine, a value of unity otherwise"><entity charOffset="35-48" id="DDI-PubMed.9506012.s19.e0" text="carbamazepine" /></sentence><sentence text=" Valproic acid relative clearance was highest in the very young and decreased in a weight-related fashion in children, with minimal changes observed in adults"><entity charOffset="1-14" id="DDI-PubMed.9506012.s20.e0" text="Valproic acid" /></sentence><sentence text=" This pattern was consistent whether valproic acid was administered alone or coadministered with phenobarbital or carbamazepine"><entity charOffset="37-50" id="DDI-PubMed.9506012.s21.e0" text="valproic acid" /><entity charOffset="97-110" id="DDI-PubMed.9506012.s21.e1" text="phenobarbital" /><entity charOffset="114-127" id="DDI-PubMed.9506012.s21.e2" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.9506012.s21.e0" e2="DDI-PubMed.9506012.s21.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s21.e0" e2="DDI-PubMed.9506012.s21.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s21.e0" e2="DDI-PubMed.9506012.s21.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s21.e1" e2="DDI-PubMed.9506012.s21.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s21.e1" e2="DDI-PubMed.9506012.s21.e2" /></sentence><sentence text=" When valproic acid was coadministered with phenobarbital or carbamazepine, valproic acid relative clearance increased as compared with that in monopharmacy"><entity charOffset="6-19" id="DDI-PubMed.9506012.s22.e0" text="valproic acid" /><entity charOffset="44-57" id="DDI-PubMed.9506012.s22.e1" text="phenobarbital" /><entity charOffset="61-74" id="DDI-PubMed.9506012.s22.e2" text="carbamazepine" /><entity charOffset="76-89" id="DDI-PubMed.9506012.s22.e3" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e0" e2="DDI-PubMed.9506012.s22.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e0" e2="DDI-PubMed.9506012.s22.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e0" e2="DDI-PubMed.9506012.s22.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e0" e2="DDI-PubMed.9506012.s22.e3" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e1" e2="DDI-PubMed.9506012.s22.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e1" e2="DDI-PubMed.9506012.s22.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e1" e2="DDI-PubMed.9506012.s22.e3" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e2" e2="DDI-PubMed.9506012.s22.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s22.e2" e2="DDI-PubMed.9506012.s22.e3" /></sentence><sentence text=" Its magnitude in the presence of carbamazepine increased in a valproic acid daily dose-related fashion"><entity charOffset="34-47" id="DDI-PubMed.9506012.s23.e0" text="carbamazepine" /><entity charOffset="63-76" id="DDI-PubMed.9506012.s23.e1" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.9506012.s23.e0" e2="DDI-PubMed.9506012.s23.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s23.e0" e2="DDI-PubMed.9506012.s23.e1" /></sentence><sentence text=" Concomitant administration of phenobarbital and valproic acid resulted in a 10% increase on valproic acid relative clearance"><entity charOffset="31-44" id="DDI-PubMed.9506012.s24.e0" text="phenobarbital" /><entity charOffset="49-62" id="DDI-PubMed.9506012.s24.e1" text="valproic acid" /><entity charOffset="93-106" id="DDI-PubMed.9506012.s24.e2" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.9506012.s24.e0" e2="DDI-PubMed.9506012.s24.e0" /><pair ddi="false" e1="DDI-PubMed.9506012.s24.e0" e2="DDI-PubMed.9506012.s24.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s24.e0" e2="DDI-PubMed.9506012.s24.e2" /><pair ddi="false" e1="DDI-PubMed.9506012.s24.e1" e2="DDI-PubMed.9506012.s24.e1" /><pair ddi="false" e1="DDI-PubMed.9506012.s24.e1" e2="DDI-PubMed.9506012.s24.e2" /></sentence><sentence text=" The clearance in female patients was approximately 10% less than that in male patients" /><sentence text="" /></document>